The present invention provides methods for treating diseases or disorders,
and methods for enhancing siRNA efficacy in RNAi, including administering
to a subject or a biological system one or more siRNAs capable of down
regulating the expression of one or more target genes and one or more
siRNAs capable of down regulating the expression of one or more negative
regulators of RNAi. The present invention also provides compositions
including one or more siRNAs, or precursors thereof, capable of down
regulating the expression of one or more target genes and comprising one
or more siRNAs, or precursors thereof, capable of down regulating the
expression of one or more negative regulators of RNAi.